Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Diamondback Drugs ® Earns Industry’s Coveted PCAB™ Accreditation
  • USA - English


News provided by

Diamondback Drugs

Jan 25, 2017, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Diamondback Drugs
Diamondback Drugs

Scottsdale, Arizona (PRWEB) January 25, 2017 -- Diamondback Drugs is pleased to announce it has received accreditation by the Pharmacy Compounding Accreditation Board ™ (PCAB), a service of the Accreditation Commission for Health Care (ACHC). Accreditation is only awarded to pharmacies that demonstrate adherence to stringent quality standards and a commitment to continuous process improvement.

We’re delighted that we have received the PCAB certification, the benchmark of quality in the industry.

Post this

“It’s extremely fulfilling to be recognized for the hard work and diligence our team has invested in helping Diamondback achieve this level of excellence. PCAB Accreditation shows our dedication to protecting our patients by practicing safe, high-quality compounding,” states pharmacist Michael Blaire, Executive Chairman and co-founder of Diamondback Drugs.

“We’re delighted that we have received the PCAB certification, the benchmark of quality in the industry. What this means is that we’ve tested our policies and procedures against the highest standards for compounding,” affirmed David Perkins, Chief Compliance Officer for Diamondback Drugs.

Very few veterinary-only compounding pharmacies have achieved this milestone. Even fewer compound sterile preparations. Blaire believes the PCAB accreditation makes it easier for veterinarians and pet parents to choose a compounding pharmacy they know meets the highest quality and safety standards in the profession.

Compounding medications is an integral part of the practice of pharmacy and the demand for these customized medications is increasing every year. Yet many people may not even be aware of its role. Written by veterinarians and other legally authorized prescribers, compounded medications are prepared for an individual patient by a specially trained pharmacist.

Examples of compounded prescriptions are:

• When an animal needs a smaller dose of a medicine that is only commercially manufactured in human adult-size doses.
• When an animal cannot tolerate or has allergies to the inactive ingredients (such as gluten or sugar) in manufactured medicines.
• When an animal refuses to take their medications due to taste.
• When a veterinarian believes a medicine is needed for his or her patient, but a manufacturer has discontinued the medicine for economic reasons.

Many pharmacies practice a small degree of compounding, while others specialize in the centuries-old practice, such as Diamondback Drugs.

With the high volume of prescriptions that are compounded each year, there has been a need for an enhanced, profession-wide system of standards by which each compounding pharmacy can test its quality processes. While Diamondback Drugs is regulated by the states in which it is licensed, PCAB Accreditation is an even more comprehensive way to ensure a compounding pharmacy is meeting the highest quality and safety standards.

To earn PCAB Accreditation, Diamondback Drugs had to complete an extensive application process, document its written policies and provide an analysis of its quality procedures. This was reviewed by the Pharmacy Compounding Accreditation Board and some of the leading figures in the field of compounding. Next, the pharmacy opened its doors for an extensive on-site inspection led by a compounding expert. Only when these stringent evaluations were completed did the Pharmacy Compounding Accreditation Board officially grant Diamondback Drugs the PCAB Accreditation and the right to use the designation “PCAB Accredited™ compounding pharmacy.

“We are honored by this new accreditation. It confirms our commitment to providing safe, personalized solutions that meet the medical needs of our patients – and the needs of the healthcare providers who rely on us for these specialized medicines,” said Michael Blaire. “We believe this will further strengthen the bond of trust between our pharmacy and the communities that we serve.”

About Diamondback Drugs

Scottsdale, Arizona-based Diamondback Drugs is a national leader in veterinary compounding and is proud to have attained both PCAB Accreditation and Vet-VIPPS certification. For more than 15 years, Diamondback Drugs has set the standard in creating customized pharmaceuticals for animals of all sizes, exclusively focusing on veterinary patients. Diamondback successfully blends the safety and science of veterinary compounding and stocks the widest range of medications, chemicals, bases and flavors and offers solutions in sterile, hazardous, and controlled substances. Learn more about Diamondback Drugs at http://www.diamondbackdrugs.com/ or call direct at 866-578-4420.

About the Pharmacy Compounding Accreditation Board

The Pharmacy Compounding Accreditation Board is a service of the Accreditation Commission for Health Care, a not-for-profit corporation established in 1986 that recognized the need for a national standards organization for health care facilities. Originally the product of 8 leading pharmacy organizations, PCAB developed the policies, criteria and processes for the accreditation of compounding pharmacies. In 2014, PCAB accreditation became a service of ACHC. The alignment of the organizations ensures that safety and compliance needs are met in the most efficient and effective manner. More information at http://achc.org/pcab

Giano Panzarella, Diamondback Drugs, http://www.diamondbackdrugs.com, +1 480-559-0630, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.